Yahoo Web Search

Search results

1. CRISPR Therapeutics AG

   NasdaqGM: CRSP

   45.44

   Add to watchlist

   Sign in to add to watchlist

   Sign In

   -0.15 (-0.33%)

   At close: Wed. Sep 11, 2024 4:00 PM EDT · Nasdaq Real Time Price (USD) · Pre-Market Time

   Full chart

   • 1D
   • 5D
   • 1M
   • 6M
   • YTD
   • 1Y
   • MAX

   • Open	45.23
     High	45.50
     Low	44.21

   • Mkt Cap	3.87B
     P/E (TTM)	N/A
     Div & Yield	N/A & N/A

   • Prev. Close	45.59
     52 Wk. Low	37.55
     52 Wk. High	91.10

   More about CRSP

   What analysts are saying

   Morningstar Bullish Published August 08 · Crispr Therapeutics is a gene editing company focused on the development of Crispr/Cas9-based therapeutics. Crispr/Cas9 stands for clustered... Read more

   Top stories

   • CRSP
     -0.33%

   CRISPR Therapeutics AG (CRSP): Among the Worst ARK Stocks According to Short Sellers

   Yahoo Finance · 3 days ago

   

   • VERX
     -1.15%
   • BLUE
     +1.96%
   • CRSP
     -0.33%

   FDA will not meet ahead of bluebird bio’s sickle cell disease gene therapy PDUFA date

   Yahoo Finance · 2 weeks ago

   

   Related stocks

   • EDIT
     Editas Medicine, Inc.
     EDIT
     3.7800
     +0.27%
   • NTLA
     Intellia Therapeutics, Inc.
     NTLA
     20.24
     +0.60%
   • TDOC
     Teladoc Health, Inc.
     TDOC
     7.30
     +0.69%
   • PACB
     Pacific Biosciences of California, Inc.
     PACB
     1.6800
     -3.45%
   • BEAM
     Beam Therapeutics Inc.
     BEAM
     24.12
     +1.99%

   More on Yahoo Finance

2. seekingalpha.com › symbol › CRSPCRISPR Therapeutics AG (CRSP) Stock Price, Quote, News & Analysis

   seekingalpha.com › symbol › CRSP

   • Cached

   3 days ago · A high-level overview of CRISPR Therapeutics AG (CRSP) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.

   • Company name: ADMA Biologics, Inc.
   • Industry: Biotechnology

   • Employees: 624
   • Market Cap: 4.29B

3. www.marketbeat.com › stocks › NASDAQCRISPR Therapeutics (CRSP) Stock Forecast & Price Target

   www.marketbeat.com › stocks › NASDAQ

   • Cached

   3 days ago · CRSP's current price target is $75.63. Learn why top analysts are making this stock forecast for CRISPR Therapeutics at MarketBeat.

   • 2.3/5

   • Email: susan.kim@crisprtx.com

4. www.marketbeat.com › stocks › NASDAQCRISPR Therapeutics (CRSP) Stock Price, News & Analysis

   www.marketbeat.com › stocks › NASDAQ

   • Cached

   6 days ago · Should You Buy or Sell CRISPR Therapeutics Stock? Get The Latest CRSP Stock Analysis, Price Target, Earnings Estimates, Headlines, and Short Interest at MarketBeat.

   • 2.3/5

   • Email: susan.kim@crisprtx.com

5. People also ask

   Is CRSP (CRSP) a good stock to buy?

   • 29 Wall Street analysts have issued ratings. Currently, 15 analysts rated CRSP as Bullish, 3 rated it Bearish, and 11 rated it Neutral. This suggests a possible increase. View 5 Seeking Alpha authors also rated the stock, and their ratings often outperform those of Wall Street analysts.

   CRISPR Therapeutics AG (CRSP) Stock Price, Quote, News & Analysis

   seekingalpha.com/symbol/CRSP

   See all results for this question

   Is CRISPR Therapeutics AG (CRSP) a good stock to buy?

   • CRISPR Therapeutics AG's stock symbol is CRSP and currently trades under NASDAQ. It’s current price per share is approximately $48.69. What are your CRISPR Therapeutics AG (CRSP) stock predictions? 29 Wall Street analysts have issued ratings. Currently, 15 analysts rated CRSP as Bullish, 3 rated it Bearish, and 11 rated it Neutral.

   CRISPR Therapeutics AG (CRSP) Stock Price, Quote, News & Analysis

   seekingalpha.com/symbol/CRSP

   See all results for this question

   What is the price target for CRSP?

   • The highest price target for CRSP is $105.00, while the lowest price target for CRSP is $30.00. The average price target represents a forecasted upside of 59.18% from the current price of $47.51. Sign-up to receive the latest news and ratings for CRSP and its competitors with MarketBeat's FREE daily newsletter.

   CRISPR Therapeutics (CRSP) Stock Forecast and Price Target 2024

   www.marketbeat.com/stocks/NASDAQ/CRSP/forecast/

   See all results for this question

   Why is CRSP stock down?

   • Since the start of this year, CRSP received approval for its VRTX-partnered one-shot gene therapy Casgevy in two blood disorders, namely sickle cell disease (SCD) and transfusion-dependent beta thalassemia (TDT), in the United States and Europe. Despite these approvals, the stock is down likely due to a lack of pipeline updates.

   CRISPR (CRSP) Loses 24% YTD: How Should You Play the Stock?

   finance.yahoo.com/news/crispr-crsp-loses-24-ytd-154300628.html

   See all results for this question

6. finance.yahoo.com › news › crispr-crsp-loses-24-ytdCRISPR (CRSP) Loses 24% YTD: How Should You Play the Stock?

   finance.yahoo.com › news › crispr-crsp-loses-24-ytd

   • Cached

   Aug 19, 2024 · CRSP is a biotech company that develops gene editing therapies with Vertex Pharmaceuticals. It has received approval for Casgevy, the first CRISPR-based gene therapy for blood disorders, but faces competition and risks.

7. www.bloomberg.com › quote › CRSP:USCRSP: CRISPR Therapeutics AG Stock Price Quote - NASDAQ GM ...

   www.bloomberg.com › quote › CRSP:US

   • Cached

   1 day ago · CRSP:US is the ticker symbol for CRISPR Therapeutics AG, a gene editing company developing transformative medicines for various diseases. Get the latest stock price, chart, news, key statistics, fundamentals and company profile on Bloomberg.

   • Employees: 458

8. stockanalysis.com › stocks › crspCRISPR Therapeutics AG (CRSP) Stock Forecast & Price Targets ...

   stockanalysis.com › stocks › crsp

   • Cached

   Sep 3, 2024 · The 16 analysts with 12-month price forecasts for CRSP stock have an average target of 74.38, with a low estimate of 30 and a high estimate of 105. The average target predicts an increase of 62.08% from the current stock price of 45.89.

9. simplywall.st › stocks › usCRISPR Therapeutics NasdaqGM:CRSP Stock Report - Simply Wall St

   simplywall.st › stocks › us

   • Cached

   4 days ago · Research CRISPR Therapeutics' (Nasdaq:CRSP) stock price, latest news & stock analysis. Find everything from its Valuation, Future Growth, Past Performance and more.